Abstract
AbstractChronic tinnitus is a common neurological disorder that affects millions of patients globally with no available successful pharmacotherapy. It can be extremely bothersome to some patients to the extent that it occasionally qualifies as a disability that can hinder them from leading a normal life. In this short communication, the author discusses how he suffered from idiopathic tinnitus and how he managed to adopt a combined pathophysiological and pharmacological approach to the reason for the first time in the medical literature that low-dose metformin might be safely and effectively repurposed to manage at least a subset of tinnitus patients while discussing the potential role of adenosine receptor agonists as potential future tinnitus therapeutics.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Aljuaid SM, Mirza AA, Habib LA, AlHarthi LA, Alansari BM, AlQahtani BG, Althobaiti YA (2020) Does caffeine intake increase the incidence of Tinnitus? A systematic review. Int Arch Otorhinolaryngol 25:e628–e632
2. Bhatt IS, Wilson N, Dias R, Torkamani A (2022) A genome-wide association study of tinnitus reveals shared genetic links to neuropsychiatric disorders. Sci Rep 12:22511
3. Colizza A, Ralli M, Turchetta R, Minni A, Greco A, De Vincentis M (2022) Otolaryngology adverse events following COVID-19 vaccines. Eur Rev Med Pharmacol Sci 26:4113–4116
4. Dardennes R, Al Anbar N, Rouillon F (2013) Propofol-interrupted Tinnitus later suppressed by Amantadine: a case-report. J Clin Pharmacol 53:356–358
5. Dattilo S, Mancuso C, Koverech G, Di Mauro P, Ontario ML, Petralia CC, Petralia A, Maiolino L, Serra A, Calabrese EJ, Calabrese V (2015) Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun Ageing 12:20